Entera Bio Ltd. (ENTX) stock
ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.26+0.26 (+8.67%)
Close on Nov 18, 2026Market cap $564.44MP/E –Yield –
Entera Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Entera Bio's total debt was $3.89M at Dec 31, 2017. For fiscal 2017 it was $3.89M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $3.89M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2017 | Dec 31, 2017 | $3.89M | – |
See a number that looks wrong?